Hydroxyethyl starch 130/0.4

Hydroxyethyl starch 130/0.4 is a new plasma substitution with medium molecular weight, which has a reliable effect of plasma volume expansion. It is more safe in clinical application and has a competive price. Since hydroxyethyl starch (40,20), a plasma substitution of low molecular weight, has a harmful effect on kidney function reported by ADR Monitoring Center of China, hydroxyethyl starch 130/0.4 will replace it and be clinically applied to the broadening field in future.

Constitutional formula: Mean molecular weight:130,000D

Description: White or almost white crystalline powder; practically odourless. Very slightly soluble in water and in alcohol, insoluble in chloroform and in ether. It dissolves in dilute solutions of alkali hydroxides.

Usage: Action and usage: Treat and prevent the deficiency of plasma volume and acute normovolemic hemodilution, make hemodynamics stable, improve internal organs perfusion, improve endothelial cell function.

Packing: 25ka/drum/case or be packed according to cutomer³s requirments.

Products Available: Hydroxyethyl Starch 130/0.4, and Sodium Chloride Injection.